NCT00141778
Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
See it on ClinicalTrials.gov ↗445 people
33.5%
66.5%
149 womenmiddle line = equal numbers296 men
- Phase
- PHASE2, PHASE3
- Paid for by
- Vanderbilt University
- Finished
- 2010-08
- Health conditions
- Atrial Fibrillation
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 59.3 years
- Age 65+
- 33.9%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or breastfeeding”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or breastfeeding”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“…must be postmenopausal for at least 1 year, status-post surgical sterilization, or if of childbearing potential, utilizing adequate birth control and willing to undergo urine beta-hcg testing prior to drug treatment and throughout the study”
- Only women past menopause
Women who could still get pregnant were turned away.
“If female, must be postmenopausal for at least 1 year, status-post surgical sterilization, or if of childbearing potential, utilizing adequate birth control and willing to undergo urine beta-hcg testing prior to drug treatment and throughou…”
Study titles and rules are shown in their original English.